Breaking News

Aptar Broadens Pharma Services Platform

Acquires Nanopharm and Gateway Analytical to accelerate customer drug development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AptarGroup has acquired two pharmaceutical services companies, Nanopharm and Gateway Analytical, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and de-risk their complex product developments.   Both acquisitions bring complementary, value-added and differentiated analytical, testing and development services for all stages of drug deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters